| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
2008-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_509e2cb6801ccdb3058db55a0566fb04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bea6852002b7e6b90bb4ffa1605709f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd15b8fe30635fb3398c51872e94c918
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af3930a0a9b81ed9ebf9bd021acc908b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a3e0af5c272a3951c10b98f0b3a991
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81acae6dd7d9536dc8c9de88ff516232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2282a09d866c6d41857c820ffb54c60 |
| publicationDate |
2009-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090092202-A |
| titleOfInvention |
ANTIBODY SPECIFICALLY BINDING TO A PHOSPHORYLATED PLC-γ PROTEIN |
| abstract |
The present invention relates to a method of inhibiting intracellular signal transduction by said phosphorylated protein by expressing an antibody specifically binding to phosphorylated protein and an expression system for expressing said antibody in a cell.n n n Since the methods and systems of the present invention can inhibit intracellular signal transduction by phosphorylated proteins, they are useful for the treatment or prevention of diseases mediated by intracellular signal transduction by phosphorylated proteins, including prostate cancer. Can be. |
| priorityDate |
2008-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |